As well as data receivedthrough the Yellow Card Scheme, the CSM and MHRA also use other sources ofinformation to monitor the safety of vaccines and medicines such as formalsafety studies, the published medical literature, information frompharmaceutical companies and other regulatory authorities throughout the world.Rare side-effects associatedwith vaccines and medicines may not have been identified or characterised inpre-licensing clinical trials.